It sounds like a joke: poppy seeds infused with opioids. Indeed, it was a plotline on the sitcom Seinfeld. But for some it has been a tragedy. People have died after drinking tea brewed from unwashed poppy seeds. And after eating lemon poppy seed bread or an everything bagel, mothers reportedly have been separated from…
Most employers have little idea what the pharmacy benefit managers they hire do with the money they exchange for the medications used by their employees, according to a KFF survey released Wednesday morning. In KFF’s latest employer health benefits survey, company officials were asked how much of the rebates collected from drugmakers by pharmacy benefit…
In her first months as a community health worker, Jee Hyo Kim helped violent crime survivors access supportive services and resources. When a client with post-traumatic stress disorder sought a therapist, she linked him to one that fit his needs. She helped clients afraid to leave their homes obtain food delivery vouchers. As one client…
When Interest Rates Go Low, Should Public Debt Go High?ROI for SDOH interventions.Consumption responses to sweetened beverage taxes.Do health care quality improvement policies work for all?“Provider respondents reported spending time equivalent of more than 100 000 full-time registered nurses per year on prior authorization. ”
Christopher Stanley, M.D., M.B.A., serves as president of Populance, after serving as chief population health officer at Sutter Health in Northern California
During a recent conference, Ceci Connolly, CEO of the Alliance of Community Health Plans, shared five things she thinks the healthcare industry should know about the upcoming election. The post 5 Things Healthcare Leaders Should Know About the 2024 Election appeared first on MedCity News.
Over half of health information organizations that reported impediments cited two or more reasons labs used as a basis for limiting or refusing to provide electronic health information
Acquisition of Mission Cancer + Blood, valued at $280 million, to offer opportunities for oncology specialists to work together to increase access to cancer detection, treatment, and research across Iowa
Ninety-two percent of organizations experienced a cyberattack in the past 12 months, a report by Proofpoint and Ponemon Institute concludes
Astellas secured an exclusive option to license global rights to an AviadoBio gene therapy in development as a one-time treatment for a certain type of frontotemporal dementia. A Phase 1/2 test of the AviadoBio gene therapy is ongoing. The post Another Astellas Gene Therapy Deal, This Time $50M for Option on AviadoBio Dementia Program appeared…